MESSENGER RNA THERAPEUTICS AND COMPOSITIONS

In the various aspects and embodiments, this disclosure provides messenger RNA (mRNA) constructs for therapeutic delivery, as well as methods for making such mRNA constructs and pharmaceutical compositions comprising the same (including mRNA vaccine compositions). In still other aspects, the inventi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AULISA, Lorenzo, HILL, Ian, GREGG, Christopher, ABSHIRE, James Robbins, HUDSON, Michael, DE, Nabanita, SAMSA, Marcelo, FARMER, William, JAIN, Rachit, DAVITT, Christopher J.H, DHAMANKAR, Himanshu
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In the various aspects and embodiments, this disclosure provides messenger RNA (mRNA) constructs for therapeutic delivery, as well as methods for making such mRNA constructs and pharmaceutical compositions comprising the same (including mRNA vaccine compositions). In still other aspects, the invention provides methods for treating patients by expression of therapeutic proteins, including for preventing or reducing probability of infection by, or illness involving, a virus. Exemplary viruses include coronaviruses (such as SARS-CoV-2 and variants therefore) and influenza viruses, among others. Dans les divers aspects et modes de réalisation, cette divulgation concerne des constructions d'ARN messager (ARNm) pour une administration thérapeutique, ainsi que des procédés de fabrication de telles constructions d'ARNm et des compositions pharmaceutiques les comprenant (y compris des compositions de vaccin à ARNm). Dans d'autres aspects encore, l'invention concerne des procédés pour traiter des patients par l'expression de protéines thérapeutiques, y compris pour la prévention ou la réduction de la probabilité d'infection par, ou d'une maladie impliquant, un virus. Des exemples de virus comprennent des coronavirus (tels que le SARS-CoV-2 et des variants de ceux-ci) et des virus de la grippe, entre autres.